Cargando...
An exploration of site effects in a multisite trial of OROS-methylphenidate for smokers with Attention Deficit/Hyperactivity Disorder
BACKGROUND: Multi-site trials, the gold standard for conducting studies in community-based settings, can mask variability across sites resulting in misrepresentation of effects in specific sites. In a placebo-controlled trial of osmotic-release oral system methylphenidate (OROS-MPH) as augmentation...
Guardado en:
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2011
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3510007/ https://ncbi.nlm.nih.gov/pubmed/21854282 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/00952990.2011.596979 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|